IHH Healthcare Bhd
OTC:IHHHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (24.2), the stock would be worth $1.12 (35% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 37.1 | $1.71 |
0%
|
| 3-Year Average | 24.2 | $1.12 |
-35%
|
| 5-Year Average | 27.5 | $1.27 |
-26%
|
| Industry Average | 32 | $1.48 |
-14%
|
| Country Average | 15.5 | $0.72 |
-58%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
$77.5B
|
/ |
Jan 2026
2.1B
|
= |
|
|
$77.5B
|
/ |
Dec 2026
2.3B
|
= |
|
|
$77.5B
|
/ |
Dec 2027
2.6B
|
= |
|
|
$77.5B
|
/ |
Dec 2028
3B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| MY |
I
|
IHH Healthcare Bhd
OTC:IHHHF
|
77.8B USD | 37.1 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.2B USD | 14.2 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.4B ZAR | 13.9 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.6B ZAR | 4.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.3B BRL | 17.8 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 10.8 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
102.1B CNY | 30.3 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 60.6 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 31 | |
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
185.7T IDR | -933.3 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 10.9 |
| Median | 15.5 |
| 70th Percentile | 23.6 |
| Max | 227 361.7 |
Other Multiples
IHH Healthcare Bhd
Glance View
In the vast landscape of global healthcare, IHH Healthcare Berhad stands as a towering presence, weaving a complex tapestry of patient care and medical excellence. Born in 2010 from a union of healthcare assets across Asia and beyond, IHH embarked on its journey to becoming one of the world's largest healthcare networks. Its reach spans more than ten countries, stretching from its strongholds in Malaysia and Singapore to burgeoning markets in Turkey, India, and Greater China. The company operates through renowned brands like Pantai, Parkway, and Acibadem, each serving as a hallmark of quality in their respective regions. By offering a comprehensive array of healthcare services, from primary to specialized care, and running top-tier hospitals and ambulatory facilities, IHH manages to touch millions of lives while ensuring an unyielding commitment to clinical excellence. The financial engine that drives IHH pivots on its robust model of vertically integrated healthcare services. Revenue pours in through a multi-faceted approach, chiefly grounded in patient fees for hospital admissions, surgical procedures, and outpatient services. IHH benefits from a strategic alignment with medical enterprises and insurance firms, ensuring a steady influx of patients while also securing long-term partnerships. The company’s emphasis on premium healthcare services, facilitated by cutting-edge technology and skilled practitioners, allows it to charge a premium price point. Moreover, IHH's investment in state-of-the-art technology and medical training bolsters its reputation as a leader in the field, further solidifying its market position. This strategic blend of geographic diversification and healthcare excellence crafts a resilient model that not only profits but also enhances the quality of life across continents.